1. Volume 74, Issue 2, Pages 140-143 (August 2018)
Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes 
Chad A. Reichard, Justin R. Gregg, Mary F. Achim, Ana M. Aparicio, Curtis A. Pettaway, Louis L. Pisters, John F. Ward, John W. Davis, Brian F. Chapin 
European Urology 
Volume 74, Issue 2, Pages (August 2018)
DOI: /j.eururo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
Percentage of PSA change from PSA nearest prior to RP and PSA nearest after RP in the setting of mCRPC. Patients who died during follow up are circled. mCRPC=metastatic castration-resistant prostate cancer; PSA=prostate-specific antigen; RP=radical prostatectomy. a Corresponds to patient number in Table 1.
European Urology  , DOI: ( /j.eururo )
Copyright © 2018 European Association of Urology Terms and Conditions